Compositions for nasal administration of pharmaceuticals
US9138410B2 · kind B2 · utility
4Cited by
44References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Mar 14, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/29
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.